Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females

Neuroscience Letters

Volumn 338, Issue 2, 2003, Pages 123-126

  Tsai, Shih Jen ^a,b   Yu, Younger W Y ^c   Chen, Tai Jui ^d   Chen, Jen Yeu ^e   Liou, Ying Jay ^e   Chen, Ming Chao ^d   Hong, Chen Jee ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Yu's Psychiatric Clinic   (Taiwan)

^d Kaohisung Kai Suan Psychiatric Hospital   (Taiwan)

^e YULI VETERANS HOSPITAL   (Taiwan)

Author keywords

Association; Catechol O methyltransferase; Event related potential; Polymorphism; Wisconsin Card Sorting Test

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; COGNITION; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINE METABOLISM; ETHNOLOGY; FEMALE; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0037468289     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01396-4     Document Type: Review

References (20)

1. Bharath S., Gangadhar B.N., Janakiramaiah N. P300 in family studies of schizophrenia: review and critique. Int. J. Psychophysiol. 38:2000;43-54.
2. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-932.
3. Chen C.H., Lee Y.U., Wei F.C., Koong F.J., Hwu H.G., Hsiao K.J. Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol. Psychiatry. 41:1997;985-987.
4. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA. 98:2001;6917-6922.
5. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. USA. 95:1998;9991-9996.
6. Herken H., Erdal M.E. Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatry Genet. 11:2001;105-109.
7. Jones G., Zammit S., Norton N., Hamshere M.L., Jones S.J., Milham C., Sanders R.D., McCarthy G.M., Jones L.A., Cardno A.G., Gray M., Murphy K.C., Owen M.J. Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. Br. J. Psychiatry. 179:2001;351-355.
8. Lachman H.M., Papolos D.F., Satio T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 6:1996;243-250.
9. Li T., Sham P.C., Vallada H., Xie T., Tang X., Murray R.M., Liu X., Collier D.A. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatry Genet. 6:1996;131-133.
10. Lotta T., Vidgren J., Tilgmann C., Umanen I., Melen K., Julkunen I., Taskinen J. Kinetics of human soluble and membrane bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 34:1995;4202-4210.
11. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry. 159:2002;652-654.
12. Nolan K.A., Volavka J., Czobor P., Cseh A., Lachman H., Saito T., Tiihonen J., Putkonen A., Hallikainen T., Kotilainen I., Rasanen P., Isohanni M., Jarvelin M.R., Karvonen M.K. Suicidal behavior in patients with schizophrenia is related to COMT polymorphism. Psychiatry Genet. 10:2000;117-124.
13. Polich J., Kok A. Cognitive and biological determinants of P300: an integrative review. Biol. Psychology. 41:1995;103-146.
14. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 18:1998;2697-2708.
15. Sohn Y.H., Kim G.W., Huh K., Kim J.S. Dopaminergic influences on the P300 abnormality in Parkinson's disease. J. Neurol. Sci. 158:1998;83-87.
16. Stanzione P., Fattapposta F., Giunti P., D'Alessio C., Tagliati M., Affricano C., Amabile G. P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroenceph. Clin. Neurophysiol. 80:1991;446-453.
17. Vidgren J., Svensson L.A., Liljas A. Crystal structure of catechol O-methyltransferase. Nature. 368:1994;354-358.
18. Wechsler D. The Wechsler Adult Intelligence Scale. 3rd Edition:1997;Psychological Corp (Harcourt), San Antonio, TX.
19. Weinshilboum R.M., Raymond F.A. Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am. J. Hum. Genet. 29:1977;216-218.
20. Yu Y.W., Lin C.H., Chen S.P., Hong C.J., Tsai S.J. Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci. Lett. 294:2000;179-181.